Marco Taglietti

Insider Reports History

Location
C/O Forest Laboratories, Inc., 909 Third Avenue, New York, NY
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marco Taglietti:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SCYNEXIS INC Chief Executive Officer, Director Common Stock 272K $816K $3.00 Apr 26, 2022 Direct
Aquestive Therapeutics, Inc. Director Stock Option (Right to Purchase) 42K $143K $3.41 Jun 11, 2025 Direct
SCYNEXIS INC Chief Executive Officer, Director Stock Option (Right to Buy) 232K Feb 4, 2022 Direct
SCYNEXIS INC Chief Executive Officer, Director Common Stock Warrant 75K Apr 26, 2022 Direct

Insider Reports Filed by Marco Taglietti

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AQST Aquestive Therapeutics, Inc. Jun 11, 2025 1 $143K 4 Jun 12, 2025 Director
AQST Aquestive Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
AQST Aquestive Therapeutics, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
AQST Aquestive Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
SCYX SCYNEXIS INC Apr 26, 2022 2 $225K 4 Apr 28, 2022 Chief Executive Officer, Director
SCYX SCYNEXIS INC Feb 4, 2022 2 $0 4 Feb 8, 2022 Chief Executive Officer, Director
AQST Aquestive Therapeutics, Inc. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director